HAE
$118.28-2.48%
Haemonetics Corporation total returns by year (including dividends)
As of market close, Oct 16, 2026
Haemonetics Corporation total returns by year (1992–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $80.15 | $118.28 | 0.0% | +47.6% | |
| 2025 | $78.08 | $80.15 | 0.0% | +2.7% | |
| 2024 | $85.51 | $78.08 | 0.0% | -8.7% | |
| 2023 | $78.65 | $85.51 | 0.0% | +8.7% | |
| 2022 | $53.04 | $78.65 | 0.0% | +48.3% | |
| 2021 | $118.75 | $53.04 | 0.0% | -55.3% | |
| 2020 | $114.90 | $118.75 | 0.0% | +3.4% | |
| 2019 | $100.05 | $114.90 | 0.0% | +14.8% | |
| 2018 | $58.08 | $100.05 | 0.0% | +72.3% | |
| 2017 | $40.20 | $58.08 | 0.0% | +44.5% | |
| 2016 | $32.24 | $40.20 | 0.0% | +24.7% | |
| 2015 | $37.42 | $32.24 | 0.0% | -13.8% | |
| 2014 | $42.13 | $37.42 | 0.0% | -11.2% | |
| 2013 | $40.84 | $42.13 | 0.0% | +3.2% | |
| 2012 | $30.61 | $40.84 | 0.0% | +33.4% | |
| 2011 | $31.59 | $30.61 | 0.0% | -3.1% | |
| 2010 | $27.58 | $31.59 | 0.0% | +14.6% | |
| 2009 | $28.25 | $27.58 | 0.0% | -2.4% | |
| 2008 | $31.51 | $28.25 | 0.0% | -10.3% | |
| 2007 | $22.51 | $31.51 | 0.0% | +40.0% | |
| 2006 | $24.43 | $22.51 | 0.0% | -7.9% | |
| 2005 | $18.11 | $24.43 | 0.0% | +34.9% | |
| 2004 | $11.95 | $18.11 | 0.0% | +51.6% | |
| 2003 | $10.73 | $11.95 | 0.0% | +11.3% | |
| 2002 | $16.96 | $10.73 | 0.0% | -36.7% | |
| 2001 | $15.44 | $16.96 | 0.0% | +9.9% | |
| 2000 | $11.91 | $15.44 | 0.0% | +29.7% | |
| 1999 | $11.38 | $11.91 | 0.0% | +4.7% | |
| 1998 | $7.00 | $11.38 | 0.0% | +62.5% | |
| 1997 | $9.44 | $7.00 | 0.0% | -25.8% | |
| 1996 | $8.88 | $9.44 | 0.0% | +6.3% | |
| 1995 | $8.63 | $8.88 | 0.0% | +2.9% | |
| 1994 | $13.88 | $8.63 | 0.0% | -37.8% | |
| 1993 | $13.09 | $13.88 | 0.0% | +6.0% | |
| 1992 | $9.47 | $13.09 | 0.0% | +38.3% |
- Annualized
- +8.3%
- 1992–2026
- Average year
- +10.4%
- 34 full years
- Best year
- +72.3%
- 2018
- Worst year
- -55.3%
- 2021
- Positive years
- 23/34
- 68% up
Annualized (CAGR)
+8.3%
1992–2026
Average year
+10.4%
34 full years
Best year
+72.3%
2018
Worst year
-55.3%
2021
Positive years
23/34
68% up
Total return by period#
Annual
-60%-40%-20%0%20%40%60%
1992+38%'92
1993+6.0%
1994-38%
1995+2.9%'95
1996+6.3%
1997-26%
1998+63%'98
1999+4.7%
2000+30%
2001+9.9%'01
2002-37%
2003+11%
2004+52%'04
2005+35%
2006-7.9%
2007+40%'07
2008-10%
2009-2.4%
2010+15%'10
2011-3.1%
2012+33%
2013+3.2%'13
2014-11%
2015-14%
2016+25%'16
2017+44%
2018+72%
2019+15%'19
2020+3.4%
2021-55%
2022+48%'22
2023+8.7%
2024-8.7%
2025+2.7%'25
2026+48%
Methodology#
Total returns, dividends reinvested, measured on HAE. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Haemonetics Corporation's average annual return?
- Since 1992, Haemonetics Corporation (HAE) has returned about 8.3% a year (the compound annual growth rate) and an average calendar-year return of 10.4%.
- What were Haemonetics Corporation's best and worst years?
- Over 1992–2026, the best year was 2018 (+72.3%) and the worst was 2021 (-55.3%).
- How often is Haemonetics Corporation up in a year?
- 23 of the 34 full years since 1992 were positive — about 68% of the time.
More on Haemonetics Corporation
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100